Skip to content

Clinical trials

Observational Nephrotic Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nephrotic Syndrome Phase: Observational Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20072
20081
20092
20104
20113
20123
20131
20151
20163
20173
20181
20191
20203
20224
20235
20247
20257
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting17
Completed17
Unknown status13
Active, not recruiting4
Not yet recruiting3
Suspended1
Terminated1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris5
Assiut University3
Mario Negri Institute for Pharmacological Research3
University of Michigan3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
University of California, San Francisco2
AHMED ABDULQADER HAMMOUDA ABOU SHALL1
Aarhus University Hospital1
Beth Israel Deaconess Medical Center1
Centre Hospitalier Universitaire de Nice1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nephrotic Syndrome58
Nephrosis, Lipoid14
Glomerulosclerosis, Focal Segmental11
Kidney Diseases8
Proteinuria8
Glomerulonephritis, Membranous7
Renal Insufficiency, Chronic6
Acute Kidney Injury2
Addison Disease2
Denys-Drash Syndrome2

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.